Interstitial Cystitis - Results from #50

Cytokines in Bladder Pain Syndrome: A Review of the Literature. May 24, 2024

Secondary Analysis of Interstitial Cystitis/Bladder Pain Syndrome Patients Enrolled in a Recurrent Urinary Tract Infection Prevention Study Provides a Novel Paradigm for Etio-Pathogenesis and Practical Management of This Infection Phenotype. May 24, 2024

Evaluating symptom severity and urinary cytokine levels in interstitial cystitis/bladder pain syndrome patients, with and without Hunner's lesions. May 19, 2024

Chronic pelvic pain of "unknown origin" in the female. May 19, 2024

Interstitial cystitis/bladder pain syndrome: when part of the posterior fornix syndrome is potentially curable surgically. May 12, 2024

Modified botulinum toxin type A injections improve symptoms associated with interstitial cystitis/bladder pain syndrome in women: a retrospective cohort study. May 7, 2024

Urinary Viral Spectrum in Patients with Interstitial Cystitis/Bladder Pain Syndrome and the Clinical Efficacy of Valacyclovir Treatment. May 5, 2024

The association between vulvodynia and interstitial cystitis/bladder pain syndrome: A systematic review. May 2, 2024

Current updates relating to treatment for interstitial cystitis/bladder pain syndrome: systematic review and network meta-analysis. April 28, 2024

Risk Classification for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Using Machine Learning Based Predictions. April 28, 2024

Treatment of chronic post-radiation cystitis with trans-urethral amniotic bladder therapy appears durable at 9 months: A clinical study. April 23, 2024

Efficacy and predictive factors of clinical response to hyaluronic acid ＋ chondroitin sulfate bladder instillations for the treatment of BPS/IC April 22, 2024

Intravesical Interferon Therapy vs Hyaluronic Acid for Pain Among Female Individuals With Interstitial Cystitis: A Randomized Clinical Trial. April 14, 2024

Effects of onabotulinum toxin-A injection on sexual function in women with refractory interstitial cystitis/bladder pain syndrome: A prospective study. April 14, 2024

UPK3A+ umbrella cell damage mediated by TLR3-NR2F6 triggers programmed destruction of urothelium in Hunner-type interstitial cystitis/painful bladder syndrome. April 7, 2024

Urinary Sphingosine-1-Phosphate as a Biomarker for Bladder Pain Syndrome. March 31, 2024

Intravesical instillation of platelet-rich plasma for treatment of interstitial cystitis/bladder pain syndrome: A pilot study. March 24, 2024

Combination of urinary biomarkers and machine-learning models provided a higher predictive accuracy to predict long-term treatment outcomes of patients with interstitial cystitis/bladder pain syndrome. March 24, 2024

Identification of PLAC8 as a Potential Biomarker for the Diagnosis of Interstitial Cystitis. March 17, 2024

Multi-omics analyses uncover metabolic signatures and gene expression profiles of interstitial cystitis/bladder pain syndrome. March 10, 2024

Page 3 of 63